Bausch Health Companies Inc (BHC) Stock: Identifying Value and Future Vision

Bausch Health Companies Inc [BHC] stock prices are down -0.92% to $8.66 at the moment. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The BHC shares have lost -2.91% over the last week, with a monthly amount drifted -7.68%, and not seem to be holding up well over a long-time horizon.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

From an analyst’s perspective:

Bausch Health Companies Inc [NYSE: BHC] stock has seen the most recent analyst activity on September 20, 2023, when Jefferies upgraded its rating to a Buy and also boosted its price target to $16 from $9. Previously, TD Cowen downgraded its rating to Market Perform on June 16, 2023. On July 29, 2022, downgrade downgraded it’s rating to Hold. RBC Capital Mkts downgraded its rating to a Sector Perform and decreased its price target to $5 on July 29, 2022. JP Morgan downgraded its rating to a Neutral. In a note dated March 24, 2021, BofA Securities downgraded an Underperform rating on this stock but restated the target price of $27.

The stock price of Bausch Health Companies Inc [BHC] has been fluctuating between $5.57 and $11.46 over the past year. Currently, Wall Street analysts expect the stock to reach $11.33 within the next 12 months. Bausch Health Companies Inc [NYSE: BHC] shares were valued at $8.66 at the most recent close of the market. An investor can expect a potential return of 30.83% based on the average BHC price forecast.

Analyzing the BHC fundamentals

The Bausch Health Companies Inc [NYSE:BHC] reported sales of 8.76B for trailing twelve months, representing a surge of 9.80%. Gross Profit Margin for this corporation currently stands at 1.0% with Operating Profit Margin at 0.11%, Pretax Profit Margin comes in at -0.04%, and Net Profit Margin reading is -0.02%. To continue investigating profitability, this company’s Return on Assets is posted at -0.01, Equity is 0.17 and Total Capital is 0.04. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at -21.91.

Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 8.57 points at the first support level, and at 8.47 for the second support level. However, for the 1st resistance point, the stock is sitting at 8.84, and for the 2nd resistance point, it is at 9.02.

Ratios To Look Out For

It’s worth pointing out that Bausch Health Companies Inc [NYSE:BHC]’s Current Ratio is 1.30. As well, the Quick Ratio is 0.94, while the Cash Ratio is 0.22. Considering the valuation of this stock, the price to sales ratio is 0.36.

Transactions by insiders

Recent insider trading involved Carson Seana, EVP, General Counsel, that happened on Mar 04 ’24 when 6313.0 shares were sold. EVP, General Counsel, Carson Seana completed a deal on Dec 05 ’23 to sell 220.0 shares. Meanwhile, EVP, General Counsel Carson Seana sold 43.0 shares on Nov 06 ’23.

Related Posts